Compare ONTO & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONTO | CRL |
|---|---|---|
| Founded | 1940 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 13.1B |
| IPO Year | 1995 | 1999 |
| Metric | ONTO | CRL |
|---|---|---|
| Price | $287.58 | $292.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $290.63 | $198.27 |
| AVG Volume (30 Days) | 744.2K | ★ 827.6K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $26.63 | N/A |
| Revenue Next Year | $16.26 | $3.04 |
| P/E Ratio | $148.79 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $118.97 | $145.47 |
| 52 Week High | $386.46 | $303.31 |
| Indicator | ONTO | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 61.22 |
| Support Level | $267.11 | $267.27 |
| Resistance Level | $288.63 | $303.31 |
| Average True Range (ATR) | 11.06 | 9.37 |
| MACD | 3.83 | 0.17 |
| Stochastic Oscillator | 95.04 | 86.35 |
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.